The final hours for 2026 Health Law Scholars applications are upon us. Don't miss out on your chance to submit an abstract for consideration!
More information on the submission process and workshop weekend is available on our website: www.slu.edu/law/health/s...
Always a pleasure to speak to the graduating M4s at Saint Louis University School of Medicine as part of their capstone course! My talk was titled "Pharmaceutical Prescribing: Pearls and Pitfalls." #MedEd
cc: @sluhealthlaw.bsky.social
A tradition like no other: for 32 years, my @slulaw.bsky.social colleague Prof. Thomas Stewart has welcomed the entire 4th year SLU School of Medicine class to our courtroom to observe a mock trial, introducing them to the nuances of medical malpractice.
Recap and 📽️📼📺: @sluhealthlaw.bsky.social 38th Annual Health Law Symposium -- A Defining Moment for Vaccine Science and Policy t.e2ma.net/share/inboun...
SLU Law Center for Health Law Studies @sluhealthlaw.bsky.social Celebrates First in the Nation Ranking in Health Care Law www.slu.edu/law/news/202...
My co-panelists @sbagen.bsky.social and @rachelsachs.bsky.social were far more eloquent and insightful -- an honor to share the stage with them! 🙂
Thanks to @doritreiss.bsky.social for live posting @nusl.bsky.social #HLC2026, and in particular, our FDA panel!
Glad to join @sbagen.bsky.social and @drsinhaesq.bsky.social on this panel at @nusl.bsky.social's annual health law conference, with very thoughtful moderation from @davidasimon.bsky.social. Thanks to @doritreiss.bsky.social for liveposting!
This was a ton of fun. (And don't worry -- I really don't care how people pronounce my name!)
Great time moderating a panel in the FDA with @sbagen.bsky.social, @rachelsachs.bsky.social, and @drsinhaesq.bsky.social at @nusl.bsky.social annual health law conference.
As usual, I butchered at least one name (Sam’s)
Great discussion! cc: @sbagen.bsky.social @rachelsachs.bsky.social @davidasimon.bsky.social @nusl.bsky.social @sluhealthlaw.bsky.social
SLU Law Center for Health Law Studies Hosts 38th Annual Symposium www.slu.edu/law/news/202... @sluhealthlaw.bsky.social
This image shows five vials of COVID-19 vaccines.
The COVID-19 #pandemic featured rapid #vaccine development & distribution, heavily reliant on the U.S. private sector, with companies profiting while retaining #patent rights.
Read: spkl.io/63328ALi4e
Subscribe: spkl.io/63325ALi4l
@drsinhaesq.bsky.social @slulaw.bsky.social
Check out the latest from the SSRN #blog which includes a recent selection of #research on medical law.
Read more: blog.ssrn.com/2026/03/24/t...
#AcademicChatter #LawSky #MedSky
Ahead of Friday’s symposium, “A Defining Moment for Vaccine and Science Policy,” Prof Michael Sinha joins the SLU Law Summations podcast to discuss what’s at risk & to preview the incredible lineup of speakers. Listen now & then register to join us.
@drsinhaesq.bsky.social @slulaw.bsky.social
THIS FRIDAY -- 38th Annual @sluhealthlaw.bsky.social Symposium: "A Defining Moment for Vaccine Science and Policy"
Podcast with Jessica Ciccone and @slulaw.bsky.social Summations: podcasts.apple.com/us/podcast/a...
Register to join us in-person or via Zoom: docs.google.com/forms/d/e/1F...
I'll be presenting at the @nusl.bsky.social Annual Health Law Conference in Boston on April 3rd, on a panel titled "The Regulatory Environment and the FDA." Looking forward to the discussion with co-panelists @sbagen.bsky.social and @rachelsachs.bsky.social and moderator @davidasimon.bsky.social!
Please join us on March 27th at @slulaw.bsky.social for the @sluhealthlaw.bsky.social 38th Annual Health Law Symposium, "A Defining Moment for Vaccine Science and Policy"
Schedule here: www.slu.edu/law/health/s...
Register to attend (in person or via Zoom) here: docs.google.com/forms/d/e/1F...
At the American College of Legal Medicine meeting @asulaw.bsky.social -- presented on the "Updates in FDA Law" panel with @medlawdan.bsky.social @sjquinney.bsky.social and Dr. Jack Snyder
This image shows a person standing on a scale.
The article traces weight loss medication history & #obesity stigma, noting a shift from personal blame to disease recognition, & argues that new drugs could reduce barriers & stigma.
Read: spkl.io/63328AvH5p
Subscribe: spkl.io/63322AvH5k
#LawSky @drsinhaesq.bsky.social
Please join us on March 27th at @slulaw.bsky.social for the @sluhealthlaw.bsky.social 38th Annual Health Law Symposium, "A Defining Moment for Vaccine Science and Policy"
Schedule here: www.slu.edu/law/health/s...
Register to attend (in person or via Zoom) here: docs.google.com/forms/d/e/1F...
Terrific guest lecture by @ghorvath.bsky.social @uclawsf.bsky.social to my Drug and Device Regulation and Innovation seminar at @slulaw.bsky.social @sluhealthlaw.bsky.social on Tuesday, focused on Incremental Innovation in medical devices.
Article here: scholar.smu.edu/scitech/vol2...
Patients viewing unbranded ads “may not be able to attribute that this information is coming from a company with a clear profit motive,” my former colleague @asarpatwari.bsky.social said at the time. Certainly true of this ad, starring tight ends but making no mention of Novartis until the very end.
A 2016 @statnews.com piece from @rebeccarobbins.bsky.social sheds light on the issue of unbranded advertising www.statnews.com/2016/08/29/e...
The PSA test has come under scrutiny in recent years because of its unreliability in detecting prostate cancer. False positive rates of 50-75%. PSA can also be high for other reasons. Some medications (like finasteride) can dramatically lower PSA. Simply put, it is not reliable as a diagnostic tool.
Catch that $NVS ad last night? It is a form of unbranded advertising. Novartis wants men to have their PSA levels checked because the company is heavily invested in prostate cancer therapies.
I am far less confident than Novo's chief counsel that their patent will not be invalidated. Recent actions by FDA/HHS/DOJ are much more likely to protect the company's prized asset #Wegovy.
Really enjoyed having @davidasimon.bsky.social @nusl.bsky.social join my "Drug and Device Regulation and Innovation" seminar today at @slulaw.bsky.social @sluhealthlaw.bsky.social to discuss his ongoing work on medical device safety (www.safemedicaldevices.org) and Data Distortions with the class!
